https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730950 Fri, 08 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/730950-fda-clears-ind-for-harbour-biomeds-hbm-7004 http://www.bioworld.com/articles/730948 Fri, 08 May 2026 09:00:00 -0400 https://www.bioworld.com/articles/730948-arrivents-muc16-napi2b-targeted-adc-gains-ind-clearance Female reproductive system and cancer cells http://www.bioworld.com/articles/730970 Thu, 07 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730970-fda-slowdown-on-tzield-sbla-underlines-cnpv-questions FDA logo on textured paper Credit: Araki Illustrations - stock.adobe.com http://www.bioworld.com/articles/730852 Thu, 07 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730852-us-fda-tries-out-1-day-inspections http://www.bioworld.com/articles/730927 Tue, 05 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730927-bio-korea-2026-kicks-off-with-spotlight-on-oligonucleotides AI generated image for researcher developing antisense oligonucleotides http://www.bioworld.com/articles/730926 Tue, 05 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730926-bio-korea-2026-us-policy-risks-shift-to-execution-framework Strategy compass http://www.bioworld.com/articles/730835 Mon, 04 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730835-bio-korea-2026-us-policy-risks-shift-to-execution-framework Strategy compass http://www.bioworld.com/articles/730770 Fri, 01 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730770-first-protac-arvinas-veppanu-wins-fda-nod-in-breast-cancer http://www.bioworld.com/articles/730751 Fri, 01 May 2026 12:00:00 -0400 https://www.bioworld.com/articles/730751-axsomes-auvelity-cleared-for-large-alzheimers-agitation-market Auvelity Credit: Axsome Therapeutics Inc. http://www.bioworld.com/articles/730745 Thu, 30 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730745-unique-trial-strategy-muddies-the-odac-waters-for-camizestrant Breast anatomy http://www.bioworld.com/articles/730792 Thu, 30 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730792-laguna-biotherapeutics-lgna-100-gains-ind-clearance Leukemia illustration http://www.bioworld.com/articles/730809 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730809-fda-looks-toward-a-future-of-continuous-real-time-trials http://www.bioworld.com/articles/730688 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730688-enterobiotix-raises-257m-for-phase-iib-of-microbiome-pill-in-ibs British pound symbol http://www.bioworld.com/articles/730686 Wed, 29 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730686-bio-korea-2026-kicks-off-with-spotlight-on-oligonucleotides AI generated image for researcher developing antisense oligonucleotides http://www.bioworld.com/articles/730788 Tue, 28 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730788-fda-proposes-withdrawing-amgens-tavneos http://www.bioworld.com/articles/730671 Tue, 28 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730671-pilatus-plt-012-takes-immunometabolic-approach-to-reprogram-tme Illustration of monoclonal antibody treatment for cancer http://www.bioworld.com/articles/730721 Tue, 28 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730721-taiho-and-araris-announce-ind-clearance-for-arc-02 Non-Hodgkin lymphoma cells in the blood flow http://www.bioworld.com/articles/730669 Tue, 28 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730669-adcoms-off-to-sluggish-start-with-odac-meeting-on-astrazeneca-drugs Meeting illustration http://www.bioworld.com/articles/730615 Fri, 24 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730615-grace-therapeutics-hits-crl-setback-with-gtx-104-despite-positive-trial Cerebral aneurysm illustration http://www.bioworld.com/articles/730606 Thu, 23 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730606-citizen-petition-asks-for-clarity-in-crl-disclosures http://www.bioworld.com/articles/730604 Thu, 23 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730604-a-free-gene-therapy-regenerons-otarmeni-approved-for-hearing-loss Boy cupping ear with soundwave graphic http://www.bioworld.com/articles/730603 Thu, 23 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730603-fda-cms-partner-to-deliver-rapidly-for-innovative-devices CMS logo and website http://www.bioworld.com/articles/730601 Thu, 23 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730601-dupi-whoopie-sanofi-regeneron-cheered-for-sales-new-approval Dupixent http://www.bioworld.com/articles/730580 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730580-fda-grants-priority-review-to-merck-daiichis-b7-h3-cancer-adc Lung cancer illustration http://www.bioworld.com/articles/730488 Tue, 21 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730488-merck-wins-us-fda-nod-for-idvynso-a-two-drug-hiv-regimen Idvynso Credit: Merck & Co. Inc. http://www.bioworld.com/articles/730472 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730472-targeted-therapies-dominate-marchs-five-nme-approvals FDA Approved seal http://www.bioworld.com/articles/730465 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730465-psychedelic-space-expanding-on-trumps-eo Green arrow on blue abstract background http://www.bioworld.com/articles/730392 Thu, 16 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730392-fda-grants-priority-review-to-merck-daiichis-b7-h3-cancer-adc Lung cancer illustration http://www.bioworld.com/articles/730431 Thu, 16 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730431-fda-clears-ind-for-naturecells-astrostem-au-for-autism Brain clay model http://www.bioworld.com/articles/730300 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730300-us-fda-cites-first-dispenser-for-violating-rx-supply-chain-act FDA sign